NIFTY 500 › Financial Services
Overview Technical Risk & rank Results Accounts Filings Guidance & governance
Guidance tracker
What CHOLAHLDNG guided, and what came next
| Filed | What the filing says | Next results: profit YoY | Revenue | Move on the day |
|---|---|---|---|---|
| 12 Nov 2026 | Intimation under Regulation 30 of the SEBI Listing Regulations enclosing the transcript of the Q2 FY27 earnings call held with analysts and investors on November 6, 2026; the transcript is also on the company website. Management (Rajive Kumaraswami, MD of Cholamandalam MS General Insurance) reported gross premium... NSE copy | No results filed since | ||
| 20 Aug 2026 | Transcript of the Q1 FY2027 earnings call held on August 14, 2026 for the quarter ended June 30, 2026, filed under Regulation 30; the call focused on the general insurance (Chola MS) business. Rajive Kumaraswami (MD, Chola MS) said gross direct premium income was Rs. 1,860 crores, up 2.6%, and gross written premium... NSE copy | +16.8 % | +18.9 % | +3.0 % |
| 15 May 2026 | Cholamandalam Financial Holdings filed the transcript of its Q4 FY26 earnings call held on May 8, 2026, made available on the company website. Management said Chola MS GDPI was INR2,048 crores for Q4 and INR7,762 crores for FY26, with the loss of crop insurance business reducing Q4 GDPI by INR124 crores and FY26 by... NSE copy | +39.3 % | +19.9 % | -1.3 % |
| 08 May 2026 | Board approved audited standalone and consolidated financial results for the year ended March 31, 2026; auditor is M/s. R.G.N. Price & Co. Board recommended a final dividend of 130%, i.e. Rs.1.30 per equity share of face value Re.1, for FY2026, subject to shareholder approval at the 77th AGM; record date is August... NSE copy | +39.3 % | +19.9 % | -1.3 % |
| 13 Feb 2026 | Intimation under Regulation 30 enclosing the transcript of the Q3 FY26 earnings conference call held with analysts and investors on February 9, 2026, also made available on the company website. Management (V. Suryanarayanan, MD of Cholamandalam MS General Insurance) said Chola MS Q3 GDPI was INR2,067 crores and... NSE copy | - | - | -0.9 % |
| 11 Nov 2025 | Transcript of the Q2 FY26 earnings conference call held November 7, 2025, filed under Regulation 30 and posted on the company website. Management (Chola MS General Insurance MD V. Suryanarayanan) said H1 gross direct premium was INR3,647 crores and quarter-2 GDPI was INR1,835 crores, with the 1/n reporting base... NSE copy | +28.7 % | +17.2 % | +0.8 % |
| 14 Aug 2025 | Intimation under Regulation 30 of SEBI Listing Regulations that the transcript of the Q1 FY26 earnings conference call held on August 8, 2025 is available on the company's website. Management (V. Suryanarayanan, MD, Cholamandalam MS General Insurance) said the Q1 claims ratio was 81%, or about 76% excluding a motor... NSE copy | +4.6 % | +17.3 % | +1.6 % |
| 14 May 2025 | Intimation under Regulation 30 of the SEBI Listing Regulations enclosing the transcript of the Q4 FY25 earnings conference call held with analysts and investors on May 9, 2025. Management said Chola MS grew at about 1.5x industry growth on a 1/N GDPI basis and 1.6x on a full GDPI basis, with gross direct premium of... NSE copy | +5.5 % | +21.5 % | - |
| 12 Feb 2025 | Filed transcript of the Q3 FY25 earnings conference call held February 7, 2025 with analysts and investors, under Regulation 30 of the SEBI Listing Regulations. Management (V. Suryanarayanan, MD, Cholamandalam MS General Insurance) said gross direct premium for the quarter was Rs. 2,003 crores, up 8% versus... NSE copy | +5.5 % | +21.5 % | - |
Filings tagged as guidance, newest first (9 in all), with the company's next results after each: profit and revenue against the same quarter a year before, and the share's move on the results day. Whether the guidance was met is for the reader to judge from both; the site does not score it. The summaries are written by an AI model from the filing and can be wrong - the filing is the source.
Governance
Management, auditors, ratings and legal matters
| Filed | Kind | What the filing says |
|---|---|---|
| 12 Nov 2026 | Legal or regulatory | Intimation under Regulation 30 of the SEBI Listing Regulations enclosing the transcript of the Q2 FY27 earnings call held with analysts and investors on November 6, 2026; the transcript is also on the company website. Management (Rajive Kumaraswami, MD of Cholamandalam MS General Insurance) reported gross premium... NSE copy |
| 15 May 2026 | Legal or regulatory, Management change | Cholamandalam Financial Holdings filed the transcript of its Q4 FY26 earnings call held on May 8, 2026, made available on the company website. Management said Chola MS GDPI was INR2,048 crores for Q4 and INR7,762 crores for FY26, with the loss of crop insurance business reducing Q4 GDPI by INR124 crores and FY26 by... NSE copy |
| 08 May 2026 | Management change | Board approved audited standalone and consolidated financial results for the year ended March 31, 2026 (statutory auditors M/s. R.G.N. Price & Co.). Board recommended a final dividend of 130% (Rs.1.30 per equity share of face value Rs.1), payable subject to shareholder approval at the 77th AGM, to be paid within 30... NSE copy |
| 08 May 2026 | Management change | Board approved audited standalone and consolidated financial results for the year ended March 31, 2026; auditor is M/s. R.G.N. Price & Co. Board recommended a final dividend of 130%, i.e. Rs.1.30 per equity share of face value Re.1, for FY2026, subject to shareholder approval at the 77th AGM; record date is August... NSE copy |
| 12 Mar 2026 | Credit rating | Cholamandalam Financial Holdings Limited filed an intimation under Regulation 30 of the SEBI LODR Regulations, 2015, dated March 12, 2026. India Ratings & Research Private Limited has affirmed the company's Non-Convertible Debentures. The instrument amount is INR 2,000 million, with rating/outlook of IND AA+/Stable. NSE copy |
| 13 Feb 2026 | Management change | Intimation under Regulation 30 enclosing the transcript of the Q3 FY26 earnings conference call held with analysts and investors on February 9, 2026, also made available on the company website. Management (V. Suryanarayanan, MD of Cholamandalam MS General Insurance) said Chola MS Q3 GDPI was INR2,067 crores and... NSE copy |
| 09 Feb 2026 | Legal or regulatory | Board meeting outcome on February 9, 2026 approved the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025; the limited review report from statutory auditor M/s. R.G.N. Price & Co. is enclosed. The Board approved, subject to NOC from stock exchanges under... NSE copy |
| 09 Feb 2026 | Legal or regulatory | Board of Cholamandalam Financial Holdings Limited approved the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, at a meeting held on February 9, 2026; the statutory auditors, R.G.N. Price & Co., issued a limited review report on the standalone results.... NSE copy |
| 07 Nov 2025 | Legal or regulatory | Board approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (meeting held November 7, 2025; auditor R.G.N. Price & Co. issued a limited review report). Standalone total income for the quarter ended September 30, 2025 was Rs. 30.07 crores, against Rs.... NSE copy |
| 07 Nov 2025 | Legal or regulatory | Board of Cholamandalam Financial Holdings approved unaudited standalone and consolidated results for the quarter and half year ended September 30, 2025 on November 7, 2025. Standalone Q2 FY26 total income was Rs 30.07 crores and profit for the period was Rs 27.16 crores, against Rs 29.13 crores and Rs 23.52 crores... NSE copy |
| 14 Aug 2025 | Legal or regulatory | Intimation under Regulation 30 of SEBI Listing Regulations that the transcript of the Q1 FY26 earnings conference call held on August 8, 2025 is available on the company's website. Management (V. Suryanarayanan, MD, Cholamandalam MS General Insurance) said the Q1 claims ratio was 81%, or about 76% excluding a motor... NSE copy |
| 10 Jul 2025 | Legal or regulatory, Management change | Cholamandalam Financial Holdings Limited responded to an NSE query dated June 22, 2025 about the signing authority for financial results submitted on May 9, 2025. Chairman M M Murugappan could not attend the May 9, 2025 Board meeting and was granted leave of absence; the Board elected B Ramaratnam, Director (DIN:... NSE copy |
| 09 May 2025 | Management change | Board meeting held on May 9, 2025 approved audited standalone and consolidated financial results for the year ended March 31, 2025, with an unmodified auditor's report from R.G.N. Price & Co. Board recommended a final dividend of 130%, i.e. Rs. 1.30 per equity share of face value Rs. 1, for FY2024-25, payable... NSE copy |
| 13 Mar 2025 | Credit rating | Cholamandalam Financial Holdings Limited filed an intimation under Regulation 30 of the SEBI LODR Regulations, 2015, dated March 13, 2025, regarding a credit rating. India Ratings & Research Private Limited has affirmed the company's Non-Convertible Debentures. The instrument covered is Non-Convertible Debentures... NSE copy |
Filings with a management change, a legal or regulatory matter or a credit rating (by their tags), or naming an auditor, a resignation or a pledge of shares; newest first (14 in all). A list of what was filed, not a judgement of the company.